![Andy Hurley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andy Hurley
Corporate Officer/Principal bei
SHIELD THERAPEUTICS PLC
Profil
Andy Hurley currently works at Shield Therapeutics Plc, as Chief Commercial Officer from 2023.
Mr. Hurley also formerly worked at Cytophage Technologies, Inc. (Old), as Director, Sumitomo Pharma America, Inc., as Vice President-Marketing & Commercial Operations, Dyax Corp., as Vice President-Sales & Marketing, Agenus, Inc., as Chief Commercial & Clinical Operations Officer from 2021 to 2022, Ocular Therapeutix, Inc., as Chief Commercial Officer from 2016 to 2017, Capgemini America, Inc., as Principal, and Syneos Health, Inc., as Senior Vice President.
Mr. Hurley received his undergraduate degree from the University of Vermont and undergraduate degree from Elkin B Mccallum Graduate School of Business.
Aktive Positionen von Andy Hurley
| Unternehmen | Position | Beginn |
|---|---|---|
| SHIELD THERAPEUTICS PLC | Corporate Officer/Principal | 10.04.2023 |
Ehemalige bekannte Positionen von Andy Hurley
| Unternehmen | Position | Ende |
|---|---|---|
| AGENUS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2022 |
| OCULAR THERAPEUTIX, INC. | Corporate Officer/Principal | 01.09.2017 |
Cytophage Technologies, Inc. (Old)
 Cytophage Technologies, Inc. (Old) BiotechnologyHealth Technology Operates as a biotechnology company | Direktor/Vorstandsmitglied | - |
| SYNEOS HEALTH, INC. | Corporate Officer/Principal | - |
Capgemini America, Inc.
 Capgemini America, Inc. Packaged SoftwareTechnology Services Provides software solutions | Corporate Officer/Principal | - |
Ausbildung von Andy Hurley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
32
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Ocular Therapeutix, Inc.
 Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capgemini America, Inc.
Capgemini America, Inc. Packaged SoftwareTechnology Services Provides software solutions | Technology Services |
Elkin B Mccallum Graduate School of Business
 Elkin B Mccallum Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shield Therapeutics Plc
 Shield Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and commercializes late stage pharmaceutical products | Health Technology |
Syneos Health, Inc.
 Syneos Health, Inc. BiotechnologyHealth Technology Provides outsourced clinical development and commercialization services to biopharmaceutical companies | Health Technology |
Cytophage Technologies, Inc. (Old)
Cytophage Technologies, Inc. (Old) BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
